AP26113,
brigatinib,
Brigatinib,
1197953-54-0,
UNII-HYW8DB273J,
Brigatinib [USAN],
AP-26113,
Brigatinib (AP26113),
HYW8DB273J,
Brigatinib (USAN),
2,4-Pyrimidinediamine, 5-chloro-N4-(2-(dimethylphosphinyl)phenyl)-N2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-,
5-Chloro-N~4~-[2-(Dimethylphosphoryl)phenyl]-N~2~-{2-Methoxy-4-[4-(4-Methylpiperazin-1-Yl)piperidin-1-Yl]phenyl}pyrimidine-2,4-Diamine,
Brigatiib,
Alunbrig (TN),
2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-,
brigatinib-ap26113,
AP 26113,
Brigatinib [USAN:INN],
CHEMBL3545311,
SCHEMBL11916361,
KS-00000TSQ,
EX-A775,
BCP17214,
BDBM50185140,
MFCD29472221,
AKOS030257612,
ZINC148723177,
CS-4278,
DB12267,
NCGC00483924-01,
(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone,
5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1- yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine,
AC-29958,
AK547077,
HY-12857,
FT-0700112,
S8229,
J3.535.964H,
D10866,
(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide,
5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine,
6GY,
ALUNBRIG,
AP26113,
A13450,
1350848-43-9,
5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-Pyrimidinediamine,